PlaqueTec recruits first ten patients in BIOPATTERN trial

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), today announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Performance-enhancing drugs or placebos? The myth at the heart of anti-doping

With Chinese swimmers getting 200 drug tests over 10 days ahead of the Paris Olympics, all eyes are on the World Anti-Doping Agency (WADA). Anti-doping

August 4, 2024

Merck KGaA avoids prosecution after cooperating with DOJ to uncover China export scheme

Merck KGaA’s subsidiary MilliporeSigma has evaded charges from the US Department of Justice after exposing an alleged eight-year scheme by a former employee and his

May 24, 2024

Dementia Incidence Tied to Long-Term Exposure to Wildfire Smoke

PHILADELPHIA — Long-term exposure to wildfire smoke was linked to later diagnoses of dementia in Southern California, a retrospective cohort study of older adults found.

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.